Evaluation of edonerpic maleate as a CRMP2 inhibitor for pain relief
Name:
Evaluation of edonerpic maleate ...
Size:
1.430Mb
Format:
PDF
Description:
Final Published Version
Author
Moutal, AubinShan, Zhiming
Miranda, Victor G
François-Moutal, Liberty
Madura, Cynthia L
Khanna, May
Khanna, Rajesh
Affiliation
Univ Arizona, Ctr Innovat Brain SciUniv Arizona Hlth Sci, Coll Med, Dept Pharmacol
Issue Date
2019-11-02
Metadata
Show full item recordPublisher
TAYLOR & FRANCIS INCCitation
Aubin Moutal, Zhiming Shan, Victor G. Miranda, Liberty François-Moutal, Cynthia L. Madura, May Khanna & Rajesh Khanna (2019) Evaluation of edonerpic maleate as a CRMP2 inhibitor for pain relief, Channels, 13:1, 498-504, DOI: 10.1080/19336950.2019.1684608Journal
CHANNELSRights
Copyright © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/).Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
We have previously reported that the microtubule-associated collapsin response mediator protein 2 (CRMP2) is necessary for the expression of chronic pain. CRMP2 achieves this control of nociceptive signaling by virtue of its ability to regulate voltage-gated calcium and sodium channels. To date, however, no drugs exist that target CRMP2. Recently, the small molecule edonerpic maleate (1 -{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl}azetidin-3-ol maleate), a candidate therapeutic for Alzheimer’s disease was reported to be a novel CRMP2 binding compound with the potential to decrease its phosphorylation level in cortical tissues in vivo. Here we sought to determine the mechanism of action of edonerpic maleate and test its possible effect in a rodent model of chronic pain. We observed: (i) no binding between human CRMP2 and edonerpic maleate; (ii) edonerpic maleate had no effect on CRMP2 expression and phosphorylation in dorsal root ganglion (DRG) neurons; (iii) edonerpic maleate-decreased calcium but increased sodium current density in DRG neurons; and (iv) edonerpic maleate was ineffective in reversing post-surgical allodynia in male and female mice. Thus, while CRMP2 inhibiting compounds remain a viable strategy for developing new mechanism-based pain inhibitors, edonerpic maleate is an unlikely candidate.Note
Open access journalISSN
1933-6950PubMed ID
31680630Version
Final published versionSponsors
National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS098772, 1R01DA042852, R01AT009716]ae974a485f413a2113503eed53cd6c53
10.1080/19336950.2019.1684608
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/).
Related articles
- CRMP2-binding compound, edonerpic maleate, accelerates motor function recovery from brain damage.
- Authors: Abe H, Jitsuki S, Nakajima W, Murata Y, Jitsuki-Takahashi A, Katsuno Y, Tada H, Sano A, Suyama K, Mochizuki N, Komori T, Masuyama H, Okuda T, Goshima Y, Higo N, Takahashi T
- Issue date: 2018 Apr 6
- Druggability of CRMP2 for Neurodegenerative Diseases.
- Authors: Khanna R, Moutal A, Perez-Miller S, Chefdeville A, Boinon L, Patek M
- Issue date: 2020 Sep 2
- Edonerpic maleate regulates glutamate receptors through CRMP2- and Arc-mediated mechanisms in response to brain trauma.
- Authors: Chen T, Yang LK, Ai P, Zhu J, Hang CH, Wang YH
- Issue date: 2022 Mar 4
- Non-SUMOylated CRMP2 decreases Na<sub>V</sub>1.7 currents via the endocytic proteins Numb, Nedd4-2 and Eps15.
- Authors: Gomez K, Ran D, Madura CL, Moutal A, Khanna R
- Issue date: 2021 Jan 21
- Differential expression of Cdk5-phosphorylated CRMP2 following a spared nerve injury.
- Authors: Moutal A, Ji Y, Bellampalli SS, Khanna R
- Issue date: 2020 Jun 22